367 related articles for article (PubMed ID: 17822364)
1. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.
Thimmulappa RK; Fuchs RJ; Malhotra D; Scollick C; Traore K; Bream JH; Trush MA; Liby KT; Sporn MB; Kensler TW; Biswal S
Antioxid Redox Signal; 2007 Nov; 9(11):1963-70. PubMed ID: 17822364
[TBL] [Abstract][Full Text] [Related]
2. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide.
Thimmulappa RK; Scollick C; Traore K; Yates M; Trush MA; Liby KT; Sporn MB; Yamamoto M; Kensler TW; Biswal S
Biochem Biophys Res Commun; 2006 Dec; 351(4):883-9. PubMed ID: 17097057
[TBL] [Abstract][Full Text] [Related]
3. The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock.
Noel S; Zheng L; Navas-Acien A; Fuchs RJ
Shock; 2014 Nov; 42(5):392-9. PubMed ID: 25105464
[TBL] [Abstract][Full Text] [Related]
4. The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection.
Tran TA; McCoy MK; Sporn MB; Tansey MG
J Neuroinflammation; 2008 May; 5():14. PubMed ID: 18474101
[TBL] [Abstract][Full Text] [Related]
5. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes.
Reisman SA; Buckley DB; Tanaka Y; Klaassen CD
Toxicol Appl Pharmacol; 2009 Apr; 236(1):109-14. PubMed ID: 19371629
[TBL] [Abstract][Full Text] [Related]
6. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
[TBL] [Abstract][Full Text] [Related]
7. The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling.
Liby K; Hock T; Yore MM; Suh N; Place AE; Risingsong R; Williams CR; Royce DB; Honda T; Honda Y; Gribble GW; Hill-Kapturczak N; Agarwal A; Sporn MB
Cancer Res; 2005 Jun; 65(11):4789-98. PubMed ID: 15930299
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes.
Yates MS; Tauchi M; Katsuoka F; Flanders KC; Liby KT; Honda T; Gribble GW; Johnson DA; Johnson JA; Burton NC; Guilarte TR; Yamamoto M; Sporn MB; Kensler TW
Mol Cancer Ther; 2007 Jan; 6(1):154-62. PubMed ID: 17237276
[TBL] [Abstract][Full Text] [Related]
9. The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy.
Xu D; Chen L; Chen X; Wen Y; Yu C; Yao J; Wu H; Wang X; Xia Q; Kong X
Cell Death Dis; 2017 Aug; 8(8):e2983. PubMed ID: 28796242
[TBL] [Abstract][Full Text] [Related]
10. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.
Yates MS; Kwak MK; Egner PA; Groopman JD; Bodreddigari S; Sutter TR; Baumgartner KJ; Roebuck BD; Liby KT; Yore MM; Honda T; Gribble GW; Sporn MB; Kensler TW
Cancer Res; 2006 Feb; 66(4):2488-94. PubMed ID: 16489057
[TBL] [Abstract][Full Text] [Related]
11. Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice.
Osburn WO; Yates MS; Dolan PD; Chen S; Liby KT; Sporn MB; Taguchi K; Yamamoto M; Kensler TW
Toxicol Sci; 2008 Jul; 104(1):218-27. PubMed ID: 18417483
[TBL] [Abstract][Full Text] [Related]
12. Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3K/AKT signaling through inhibition of the lipid phosphatase PTEN.
Pitha-Rowe I; Liby K; Royce D; Sporn M
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5339-47. PubMed ID: 19494206
[TBL] [Abstract][Full Text] [Related]
13. Triterpenoid CDDO-IM protects against lipopolysaccharide-induced inflammatory response and cytotoxicity in macrophages: The involvement of the NF-κB signaling pathway.
Ahmed H; Amin U; Sun X; Pitts DR; Li Y; Zhu H; Jia Z
Exp Biol Med (Maywood); 2022 Apr; 247(8):683-690. PubMed ID: 35034476
[TBL] [Abstract][Full Text] [Related]
14. CDDO-Im exerts antidepressant-like effects via the Nrf2/ARE pathway in a rat model of post-stroke depression.
Hou X; Liu H; Ping Y; Zhang F; Zhi L; Jiang X; Zhang F; Song C; Zhang Z; Song J
Brain Res Bull; 2021 Aug; 173():74-81. PubMed ID: 33991607
[TBL] [Abstract][Full Text] [Related]
15. Cytoprotection of human endothelial cells against oxidative stress by 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im): application of systems biology to understand the mechanism of action.
Wang X; Bynum JA; Stavchansky S; Bowman PD
Eur J Pharmacol; 2014 Jul; 734():122-31. PubMed ID: 24703885
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity.
Aleksunes LM; Goedken MJ; Rockwell CE; Thomale J; Manautou JE; Klaassen CD
J Pharmacol Exp Ther; 2010 Oct; 335(1):2-12. PubMed ID: 20605904
[TBL] [Abstract][Full Text] [Related]
17. Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice.
Sussan TE; Rangasamy T; Blake DJ; Malhotra D; El-Haddad H; Bedja D; Yates MS; Kombairaju P; Yamamoto M; Liby KT; Sporn MB; Gabrielson KL; Champion HC; Tuder RM; Kensler TW; Biswal S
Proc Natl Acad Sci U S A; 2009 Jan; 106(1):250-5. PubMed ID: 19104057
[TBL] [Abstract][Full Text] [Related]
18. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide.
Shin S; Wakabayashi J; Yates MS; Wakabayashi N; Dolan PM; Aja S; Liby KT; Sporn MB; Yamamoto M; Kensler TW
Eur J Pharmacol; 2009 Oct; 620(1-3):138-44. PubMed ID: 19698707
[TBL] [Abstract][Full Text] [Related]
19. CDDO-Im ameliorates osteoarthritis and inhibits chondrocyte apoptosis in mice via enhancing Nrf2-dependent autophagy.
Dong J; Zhang KJ; Li GC; Chen XR; Lin JJ; Li JW; Lv ZY; Deng ZZ; Dai J; Cao W; Jiang Q
Acta Pharmacol Sin; 2022 Jul; 43(7):1793-1802. PubMed ID: 34754093
[TBL] [Abstract][Full Text] [Related]
20. The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in mice.
Reddy NM; Suryanaraya V; Yates MS; Kleeberger SR; Hassoun PM; Yamamoto M; Liby KT; Sporn MB; Kensler TW; Reddy SP
Am J Respir Crit Care Med; 2009 Nov; 180(9):867-74. PubMed ID: 19679692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]